BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5639737)

  • 1. Antifibrinolytic therapy for intracranial aneurysms.
    Mullan S; Dawley J
    J Neurosurg; 1968 Jan; 28(1):21-3. PubMed ID: 5639737
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptokinase clot lysis time in patients with ruptured intracranial aneurysms.
    Geronemus R; Herz DA; Shulman K
    J Neurosurg; 1974 Apr; 40(4):499-503. PubMed ID: 4814382
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of antifibrinolytic substances in ruptured intracranial aneurysms.
    Norlén G; Thulin CA
    Neurochirurgia (Stuttg); 1969 May; 12(3):100-2. PubMed ID: 5790480
    [No Abstract]   [Full Text] [Related]  

  • 4. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrinolytics in the treatment of subarachnoid hemorrhages due to ruptured aneurysms.
    Schisano G
    J Neurosurg Sci; 1975; 19(1-2):79-80. PubMed ID: 1082929
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring antifibrinolytic therapy in subarachnoid hemorrhage.
    Smith RR; Upchurch JJ
    J Neurosurg; 1973 Mar; 38(3):339-44. PubMed ID: 4268202
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.
    Nibbelink DW; Torner JC; Henderson WG
    Stroke; 1975; 6(6):622-9. PubMed ID: 1198627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of antifibrinolytic, edema-preventing and hypotensive agents in the prevention of recurrent bleeding from intracranial aneurysms].
    Bromowicz J; Bryniarska D; Koniar-Danilewicz H; Danilewicz B
    Neurol Neurochir Pol; 1979; 13(6):647-51. PubMed ID: 514441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage.
    Adams HP
    Stroke; 1982; 13(2):256-9. PubMed ID: 7039006
    [No Abstract]   [Full Text] [Related]  

  • 10. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrinolytic activity during administration of epsilon-aminocaproic acid.
    Nibbelink DW
    Stroke; 1971; 2(6):555-8. PubMed ID: 5164583
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.
    Spallone A
    Acta Neurochir (Wien); 1982; 63(1-4):245-50. PubMed ID: 6179402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
    Adams HP; Nibbelink DW; Torner JC; Sahs AL
    Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania.
    Corkill G
    Med J Aust; 1974 Mar; 1(13):468-70. PubMed ID: 4830928
    [No Abstract]   [Full Text] [Related]  

  • 15. Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid.
    Sonntag VK; Stein BM
    J Neurosurg; 1974 Apr; 40(4):480-5. PubMed ID: 4814379
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study.
    Kassell NF; Torner JC; Adams HP
    J Neurosurg; 1984 Aug; 61(2):225-30. PubMed ID: 6737046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
    Burchiel KJ; Schmer G
    J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of aminocaproic acid and nicardipine in treatment of aneurysmal subarachnoid hemorrhage.
    Beck DW; Adams HP; Flamm ES; Godersky JC; Loftus CM
    Stroke; 1988 Jan; 19(1):63-7. PubMed ID: 3336904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211.
    Shaw MD; Miller JD
    Lancet; 1974 Oct; 2(7884):847-8. PubMed ID: 4138300
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifibrinolytic therapy in the treatment of subarachnoid haemorrhage caused by arterial aneurysms.
    Profeta G; Castellano F; Guarnieri L; Cigliano A; Amborsio A
    J Neurosurg Sci; 1975; 19(1-2):77-8. PubMed ID: 1221103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.